Shan F - Search Results

1

Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy.

Li Z, You Y, Griffin N, Feng J, Shan F. Li Z, et al. Among authors: shan f. Int Immunopharmacol. 2018 Aug;61:178-184. doi: 10.1016/j.intimp.2018.05.020. Epub 2018 Jun 7. Int Immunopharmacol. 2018. PMID: 29885638 Review.

2

Dendritic cell vaccine modified by Ag85A gene enhances anti-tumor immunity against bladder cancer.

Zhang P, Wang J, Wang D, Wang H, Shan F, Chen L, Hou Y, Wang E, Lu CL. Zhang P, et al. Among authors: shan f. Int Immunopharmacol. 2012 Nov;14(3):252-60. doi: 10.1016/j.intimp.2012.07.014. Epub 2012 Aug 9. Int Immunopharmacol. 2012. PMID: 22884511

3

Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).

Li W, Chen W, Herberman RB, Plotnikoff NP, Youkilis G, Griffin N, Wang E, Lu C, Shan F. Li W, et al. Among authors: shan f. Cancer Lett. 2014 Mar 28;344(2):212-22. doi: 10.1016/j.canlet.2013.10.029. Epub 2013 Nov 26. Cancer Lett. 2014. PMID: 24291668

4

Low dose naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs).

Meng J, Meng Y, Plotnikoff NP, Youkilis G, Griffin N, Shan F. Meng J, et al. Among authors: shan f. Int Immunopharmacol. 2013 Dec;17(4):1084-9. doi: 10.1016/j.intimp.2013.10.012. Int Immunopharmacol. 2013. PMID: 24455776

5

Methionine enkephalin (MENK) improves lymphocyte subpopulations in human peripheral blood of 50 cancer patients by inhibiting regulatory T cells (Tregs).

Wang Q, Gao X, Yuan Z, Wang Z, Meng Y, Cao Y, Plotnikoff NP, Griffin N, Shan F. Wang Q, et al. Among authors: shan f. Hum Vaccin Immunother. 2014;10(7):1836-40. doi: 10.4161/hv.28804. Hum Vaccin Immunother. 2014. PMID: 25424790 Free PMC article.

6

CD226 as a genetic adjuvant to enhance immune efficacy induced by Ag85A DNA vaccination.

Li Y, Yang F, Zhu J, Sang L, Han X, Wang D, Shan F, Li S, Sun X, Lu C. Li Y, et al. Among authors: shan f. Int Immunopharmacol. 2015 Mar;25(1):10-8. doi: 10.1016/j.intimp.2014.12.036. Epub 2015 Jan 10. Int Immunopharmacol. 2015. PMID: 25582686

7

Methionine enkephalin (MENK) inhibits tumor growth through regulating CD4+Foxp3+ regulatory T cells (Tregs) in mice.

Li X, Meng Y, Plotnikoff NP, Youkilis G, Griffin N, Wang E, Lu C, Shan F. Li X, et al. Among authors: shan f. Cancer Biol Ther. 2015;16(3):450-9. doi: 10.1080/15384047.2014.1003006. Cancer Biol Ther. 2015. PMID: 25701137 Free PMC article.

8

Metabolomic analysis revealed glycylglycine accumulation in astrocytes after methionine enkephalin administration exhibiting neuron protective effects.

Zhao C, Du H, Xu L, Wang J, Tang L, Cao Y, Li C, Wang Q, Liu Y, Shan F, Feng J, Xu F, Gao P. Zhao C, et al. Among authors: shan f. J Pharm Biomed Anal. 2015 Nov 10;115:48-54. doi: 10.1016/j.jpba.2015.06.028. Epub 2015 Jun 24. J Pharm Biomed Anal. 2015. PMID: 26163404

9

A novel role for RGMa in modulation of bone marrow-derived dendritic cells maturation induced by lipopolysaccharide.

Xu X, Gao Y, Shan F, Feng J. Xu X, et al. Among authors: shan f. Int Immunopharmacol. 2016 Apr;33:99-107. doi: 10.1016/j.intimp.2016.02.008. Epub 2016 Feb 17. Int Immunopharmacol. 2016. PMID: 26896667

10

Methionine enkephalin, its role in immunoregulation and cancer therapy.

Zhao D, Plotnikoff N, Griffin N, Song T, Shan F. Zhao D, et al. Among authors: shan f. Int Immunopharmacol. 2016 Aug;37:59-64. doi: 10.1016/j.intimp.2016.02.015. Epub 2016 Feb 24. Int Immunopharmacol. 2016. PMID: 26927200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

577 results

Search Page

Filters